Prana Biotechnology
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
460 Bourke St L 3, Melbourne, Victoria, ...Website
www.pranabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Prana Biotechnology
Prana Biotechnology Limited develops therapies for the treatment of Alzheimer's disease, Huntington disease, and other neurodegenerative disorders in Australia. Its lead drug candidates include PBT2 for the treatment of Alzheimers and Huntingtons diseases; and PBT434 for the treatment of Parkinsonian movement disorders. The company is also developing PBT519 for the treatment of brain cancer. It also has a library of approximately 1000 metal protein attenuating compounds. The company has a research collaboration agreement with Takeda Pharmaceuticals International, Inc. to slow or prevent neurodegeneration of the gastrointestinal system through PBT434, an investigational movement disorders compound. Prana Biotechnology Limited was founded in 1997 and is based in Parkville,...Explore more
Prana Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prana Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Prana Biotechnology launches new products
Click to see if Prana Biotechnology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Prana Biotechnology recently announced quarterly report
Prana Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Prana Biotechnology has new funding data
Check out if Prana Biotechnology is spiking on competitors!
Check if Prana Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Prana Biotechnology
Recommended Actions
Reach out to Masked Content who joined Prana Biotechnology as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Prana Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Prana Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Prana Biotechnology.
Prana Biotechnology News & Media
Is Prana Biotechnology Limited’s (ASX:PBT) CEO Pay Justified?
Geoffrey Kempler has been the CEO of Prana Biotechnology Limited (ASX:PBT) since 2005. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of Read More...Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 as a Potential Treatment for MSA
MELBOURNE, Australia & SAN FRANCISCO--(BUSINESS WIRE)--PBT434 prevents alpha-synuclein aggregation, preserves neurons, reduces glial cell inclusions and slows motor dysfunction in an animal model of MSA
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Prana Biotechnology
Sign Up For FreeTo access detailed company insights
Prana Biotechnology Limited develops therapies for the treatment of Alzheimer's disease, Huntington disease, and other neurodegenerative disorders in Australia. Its lead drug candidates include PBT2 for the treatment of Alzheimers and Huntingtons diseases; and PBT434 for the treatment of Parkinsonian movement disorders. The company is also developi... Read More
